FAIRFIELD, Conn., Aug. 11, 2014 /PRNewswire/ -- Competitive
Technologies, Inc., (OTCQX: CTTC) (CTI), names
William Lipford, the current Midwest
Regional Sales Manager for CTI, U.S. division head of product
sales. In his new role, he will be responsible to direct all U.S.
sales of CTI's flagship product, the Calmare® Pain Therapy device,
and oversee the expansion of CTI's independent, distributor sales
force across the United
States.
"To effectively grow U.S. product sales with consistency, we
believe internalizing sales management can help focus our efforts,
increase revenues and reduce expenses," said Competitive
Technologies President & CEO Conrad
Mir. "We believe that such a task needs a sales professional
with Bill's skill-set and discipline in the medical device sector.
He stands to be an integral addition to CTI management."
This promotion replaces the consultant, sales management role of
Joel Bradus, who has chosen to
pursue other endeavors.
"We wish Joel success in his new opportunities," commented Mr.
Mir.
Physicians interested in learning more about Calmare are
encouraged to reach out to Bill
Lipford at wlipford@competitivetech.net.
About Bill Lipford
Bill started his medical technologies career at Kimberly-Clark
Corporation covering the Michigan
and Ohio regions. He later joined
Medical Development Corporation/Bard in the same region setting up
distribution centers for its line of medical disposables. He set
the existing sales record (2M) for the largest medical device
installation in a single hospital (Michigan) facility as District Manager for
Ivac Corporation/Eli Lilly, where he introduced a new IV therapy
infusion device and electronic thermometry. He accomplished the
same for Air Shields Corporation (Healthdyne) when he helped launch
a new IV medical infusion division. At Pharmacia Corporation, he
helped introduce a home programmable ambulatory infusion device for
cartridge-based chemotherapy and PCA pumps (Pharmacia/Deltec). Bill
acquired his extensive knowledge in selling electronic stimulation
devices during his time with Zynex Medical where he served as a
manufacturer's rep covering the Michigan and Ohio areas.
Mr. Lipford has a Bachelor's degree from Michigan State University.
About the Company
Competitive Technologies Inc., the pain mitigation company,
develops and commercializes innovative wound and pain management
products and technologies. CTI holds the 510k clearance on its
flagship product, the non-invasive Calmare® Pain Therapy
Device, which grants it an exclusive right to sell, market,
research and develop the medical device. The Company is the
exclusive licensed global distributor of Calmare.
Forward-Looking Statement
Certain statements contained in this press release are
forward-looking statements that involve risks and uncertainties.
The statements contained herein that are not purely historical are
forward looking statements within the meaning of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended. Forward-looking
statements deal with the Company's current plans, intentions,
beliefs and expectations and statements of future economic
performance. Forward-looking statements involve known and unknown
risks and uncertainties that may cause the Company's actual results
in future periods to differ materially from what is currently
anticipated. Factors that could cause or contribute to such
differences include those discussed from time to time in reports
filed by the Company with the Securities and Exchange Commission.
The Company cannot guarantee its future results, levels of
activity, performance or achievements.
Contacts:
|
|
Competitive
Technologies,
Inc.
|
JV Public
Relations
|
Conrad
Mir
|
Janet
Vasquez
|
President and
CEO
|
Managing
Director
|
cmir@competitivetech.net
|
jvasquez@jvprny.com
|
973.798.8882
|
212.645.5498
|
www.competitivetech.net
SOURCE Competitive Technologies, Inc.